Agenus (AGEN) Cash from Operations Growth (5y) (2015 - 2026)
Agenus (AGEN) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Agenus | 234.48 Mn | 199.48 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40% |
| Dec 31, 2025 | 14.13% |
| Sep 30, 2025 | 14.16% |
| Jun 30, 2025 | 11.56% |
| Mar 31, 2025 | 5.78% |
| Dec 31, 2024 | 2.05% |
| Sep 30, 2024 | -13.91% |
| Jun 30, 2024 | -1.35% |
| Mar 31, 2024 | -20.10% |
| Dec 31, 2023 | -2.45% |
| Sep 30, 2023 | -21.54% |
| Jun 30, 2023 | -14.51% |
| Mar 31, 2023 | -7.77% |
| Dec 31, 2022 | -12.91% |
| Sep 30, 2022 | -4.20% |
| Jun 30, 2022 | -9.66% |
| Mar 31, 2022 | -28.71% |
| Dec 31, 2021 | -27.98% |
| Sep 30, 2021 | 40.73% |
| Jun 30, 2021 | -37.99% |